Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ELI LILLY & Co
Report date December 31, 2011 · Filed February 16, 2012
Section 16 reporting ended · disclosed 2012-02-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 51,186 |
Ending reported balance
After 2011-12-29 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2011-12-16 · Gift · Disposed 40 · Balance 51,226 Row 2 · 2011-12-20 · Gift · Disposed 20 · Balance 51,206 Row 3 · 2011-12-29 · Gift · Disposed 20 · Balance 51,186 |
| Common StockSEC Table I · non-derivative | Indirect401(k) | 6,869 |
Reported balance
Holding disclosure · report date 2011-12-31 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 6,869 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2012 Filed Feb 2, 2012 20:43 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 87,924 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-006939 · doc4.xml · derivative · entry 4 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 87,924 shares Expires 2012-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:43 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 36,463 | $39.74 | $1,449,039.62 |
DisclosureSEC source: 0001209191-12-006939 · doc4.xml · nonDerivative · entry 2 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,647 Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 20:43 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 87,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-006939 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2011 Filed Feb 16, 2012 20:00 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 20 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-010739 · doc5.xml · nonDerivative · entry 3 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,186 Read SEC document |
| December 20, 2011 Filed Feb 16, 2012 20:00 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 20 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-010739 · doc5.xml · nonDerivative · entry 2 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,206 Read SEC document |
| December 16, 2011 Filed Feb 16, 2012 20:00 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 40 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-010739 · doc5.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,226 Read SEC document |
| December 12, 2011 Filed Dec 14, 2011 16:21 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,787 | $39.10 | $226,271.70 |
DisclosureSEC source: 0001209191-11-061194 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,266 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011. F2 · price: This transaction was executed in multiple trades at prices ranging from $39.06 to $39.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 11, 2011 Filed Nov 14, 2011 17:08 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,700 | $37.55 | $214,035.00 |
DisclosureSEC source: 0001209191-11-055635 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,053 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011. Read SEC document |
| October 11, 2011 Filed Oct 13, 2011 15:36 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,700 | $38.10 | $217,170.00 |
DisclosureSEC source: 0001209191-11-051643 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,753 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011. F2 · price: This transaction was executed in multiple trades at prices ranging from $38.05 to $38.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 12, 2011 Filed Sep 14, 2011 14:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,700 | $35.91 | $204,687.00 |
DisclosureSEC source: 0001209191-11-047782 · doc4.xml · nonDerivative · entry 2 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,453 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011. Read SEC document |
| August 26, 2011 Filed Sep 14, 2011 14:45 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-047782 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,153 Read SEC document |
| August 11, 2011 Filed Aug 12, 2011 18:47 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,700 | $33.94 | $193,458.00 |
DisclosureSEC source: 0001209191-11-043960 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,298 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011. F2 · price: This transaction was executed in multiple trades at prices ranging from $33.90 to $34.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 11, 2011 Filed Jul 13, 2011 18:36 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,700 | $37.39 | $213,123.00 |
DisclosureSEC source: 0001209191-11-039364 · doc4.xml · nonDerivative · entry 3 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,998 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011. F2 · price: This transaction was executed in multiple trades at prices ranging from $37.35 to $37.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 01, 2011 Filed Jul 13, 2011 18:36 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 554 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-039364 · doc4.xml · nonDerivative · entry 2 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,698 Read SEC document |
| June 28, 2011 Filed Jul 13, 2011 18:36 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 55 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-039364 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,252 Read SEC document |
| June 13, 2011 Filed Jun 15, 2011 13:45 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,700 | $37.25 | $212,325.00 |
DisclosureSEC source: 0001209191-11-034699 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,307 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011. F2 · price: This transaction was executed in multiple trades at prices ranging from $37.20 to $37.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 11, 2011 Filed May 13, 2011 13:15 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,700 | $38.21 | $217,797.00 |
DisclosureSEC source: 0001209191-11-028166 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,007 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011. F2 · price: This transaction was executed in multiple trades at prices ranging from $38.18 to $38.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 11, 2011 Filed Apr 12, 2011 19:30 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 5,700 | $35.76 | $203,832.00 |
DisclosureSEC source: 0001209191-11-022593 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,707 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2011. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.73 to $35.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 16, 2011 Filed Feb 17, 2011 21:34 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,100 | $34.49 | $106,919.00 |
DisclosureSEC source: 0001209191-11-010612 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,407 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010. Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 22:56 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 82,942 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-006873 · doc4.xml · derivative · entry 4 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 82,942 shares Expires 2011-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 22:56 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 31,555 | $34.77 | $1,097,167.35 |
DisclosureSEC source: 0001209191-11-006873 · doc4.xml · nonDerivative · entry 2 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,507 Read SEC document |
| February 01, 2011 Filed Feb 3, 2011 22:56 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 82,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-006873 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,062 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2011 Filed Jan 27, 2011 23:11 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 87,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005340 · doc4.xml · derivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,924 Underlying: Common Stock · 87,924 shares Expires 2012-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 14, 2011 Filed Jan 18, 2011 18:24 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,100 | $34.87 | $108,097.00 |
DisclosureSEC source: 0001209191-11-003397 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,930 F1 · kind: The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010. Read SEC document |
| December 16, 2010 Filed Dec 17, 2010 20:54 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,100 | $35.10 | $108,810.00 |
DisclosureSEC source: 0001209191-10-061374 · doc4.xml · nonDerivative · entry 4 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,030 F1 · kind: The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010. Read SEC document |
| December 09, 2010 Filed Dec 17, 2010 20:54 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 105 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-10-061374 · doc4.xml · nonDerivative · entry 3 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,130 Read SEC document |
| December 07, 2010 Filed Dec 17, 2010 20:54 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 60 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-10-061374 · doc4.xml · nonDerivative · entry 2 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,235 Read SEC document |
| December 06, 2010 Filed Dec 17, 2010 20:54 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 45 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-10-061374 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,295 Read SEC document |
| November 16, 2010 Filed Nov 17, 2010 19:10 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,100 | $34.43 | $106,733.00 |
DisclosureSEC source: 0001209191-10-055440 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,340 F1 · kind: The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010. Read SEC document |
| October 15, 2010 Filed Oct 19, 2010 17:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,100 | $37.65 | $116,715.00 |
DisclosureSEC source: 0001209191-10-050849 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,440 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010. Read SEC document |
| September 16, 2010 Filed Sep 17, 2010 19:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,100 | $35.55 | $110,205.00 |
DisclosureSEC source: 0001209191-10-046772 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,540 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010. Read SEC document |
| August 16, 2010 Filed Aug 18, 2010 16:32 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 3,100 | $35.33 | $109,523.00 |
DisclosureSEC source: 0001209191-10-043118 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,640 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010. Read SEC document |
| June 21, 2010 Filed Jan 31, 2011 14:55 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 1,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005644 · doc5.xml · nonDerivative · entry 4 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,930 Read SEC document |
| May 03, 2010 Filed Jan 31, 2011 14:55 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 145 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005644 · doc5.xml · nonDerivative · entry 3 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,090 Read SEC document |
| April 28, 2010 Filed Jan 31, 2011 14:55 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 175 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005644 · doc5.xml · nonDerivative · entry 2 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,235 Read SEC document |
| March 22, 2010 Filed Jan 31, 2011 14:55 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 330 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-005644 · doc5.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,410 Read SEC document |
| February 01, 2010 Filed Feb 3, 2010 16:06 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 51,249 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-10-006352 · doc4.xml · derivative · entry 4 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Est Markets BU 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 51,249 shares Expires 2010-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2010 Filed Feb 3, 2010 16:06 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 17,669 | $35.20 | $621,948.80 |
DisclosureSEC source: 0001209191-10-006352 · doc4.xml · nonDerivative · entry 2 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Est Markets BU 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,740 Read SEC document |
| February 01, 2010 Filed Feb 3, 2010 16:06 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 51,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-10-006352 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Est Markets BU 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2010 Filed Jan 28, 2010 23:03 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 82,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-10-005333 · doc4.xml · derivative · entry 3 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Est Markets BU 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,942 Underlying: Common Stock · 82,942 shares Expires 2011-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| January 26, 2010 Filed Jan 28, 2010 23:03 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 4,125 | $36.16 | $149,160.00 |
DisclosureSEC source: 0001209191-10-005333 · doc4.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Est Markets BU 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,160 Read SEC document |
| December 22, 2009 Filed Feb 3, 2010 17:07 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 244 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-10-006386 · doc5.xml · nonDerivative · entry 3 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Est Markets BU 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,035 Read SEC document |
| June 22, 2009 Filed Feb 3, 2010 17:07 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 630 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-10-006386 · doc5.xml · nonDerivative · entry 2 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Est Markets BU 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,279 Read SEC document |
| March 13, 2009 Filed Feb 3, 2010 17:07 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 630 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-10-006386 · doc5.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP and Pres, Est Markets BU 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,909 Read SEC document |
| January 27, 2009 Filed Jan 29, 2009 22:34 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 51,249 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-005395 · doc4.xml · derivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP, Global Marketing & Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,249 Underlying: Common Stock · 51,249 shares Expires 2010-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| December 08, 2008 Filed Feb 12, 2009 16:25 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 75 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-008373 · doc5.xml · nonDerivative · entry 4 Carmine Bryce D. · CIK 0001430788 · EVP, Global Marketing & Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,631 Read SEC document |
| December 08, 2008 Filed Feb 12, 2009 16:25 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 60 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-008373 · doc5.xml · nonDerivative · entry 3 Carmine Bryce D. · CIK 0001430788 · EVP, Global Marketing & Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,706 Read SEC document |
| December 08, 2008 Filed Feb 12, 2009 16:25 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-008373 · doc5.xml · nonDerivative · entry 2 Carmine Bryce D. · CIK 0001430788 · EVP, Global Marketing & Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,766 Read SEC document |
| June 17, 2008 Filed Feb 12, 2009 16:25 UTC | ELI LILLY & Co LLY · Entity 2794 | GiftCommon Stock | 312 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-09-008373 · doc5.xml · nonDerivative · entry 1 Carmine Bryce D. · CIK 0001430788 · EVP, Global Marketing & Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,916 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.